Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stiripentol in Primary Hyperoxaluria
NCT06465472Phase 3Not yet recruiting
- Sponsor
- Biocodex
- Start
- Aug 2024
- Primary completion
- Aug 2030
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of stiripentol in Primary Hyperoxaluria Type 1 (PH1), Primary Hyperoxaluria Type 2 (PH2), primary hyperoxaluria type 3 (PH3), sponsored by Biocodex. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
stiripentol
03
Conditions
Primary Hyperoxaluria Type 1 (PH1)Primary Hyperoxaluria Type 2 (PH2)primary hyperoxaluria type 3 (PH3)
Beyond the preview
Go deeper on NCT06465472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06465472.